CompanyPrivateIncheon, South Korea

Samsung Bioepis

ClinicalTrials.gov

8-KSep 3Latest SEC filing, period to Sep 3

Sep 1Latest story

September 2026

Samsung Bioepis gets label supplement approved for Byooviz ranibizumab biosimilar

Sep 1Regulatory decisionBiogen Harrow Inc